|
Hester Biosciences Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
2107.75 Cr.
|
P/BV
|
5.85
|
Book Value (Rs.)
|
423.46
|
|
52 Week High/Low (Rs.)
|
2684/1239
|
FV/ML
|
10/1
|
P/E(X)
|
37.88
|
|
Bookclosure
|
14/07/2026
|
EPS (Rs.)
|
65.40
|
Div Yield (%)
|
0.44
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 67.57 | 33.89 | 24.88 | 32.96 | 46.41 |
| Diluted EPS (Rs.) | 67.57 | 33.89 | 24.88 | 32.96 | 46.41 |
| Cash EPS (Rs.) | 82.28 | 48.82 | 39.65 | 52.10 | 65.41 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 423.46 | 369.41 | 356.03 | 339.19 | 314.32 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 423.46 | 369.41 | 356.03 | 339.19 | 314.32 |
| Revenue From Operations / Share (Rs.) | 390.97 | 365.70 | 357.99 | 312.79 | 276.25 |
| PBDIT / Share (Rs.) | 113.25 | 76.38 | 75.58 | 77.30 | 86.66 |
| PBIT / Share (Rs.) | 91.06 | 56.63 | 55.39 | 52.97 | 67.17 |
| PBT / Share (Rs.) | 81.65 | 41.70 | 32.14 | 42.02 | 62.39 |
| Net Profit / Share (Rs.) | 60.08 | 29.07 | 19.46 | 27.77 | 45.92 |
| NP After MI And SOA / Share (Rs.) | 65.40 | 32.31 | 22.20 | 31.30 | 46.41 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 28.96 | 20.88 | 21.11 | 24.71 | 31.37 |
| PBIT Margin (%) | 23.28 | 15.48 | 15.47 | 16.93 | 24.31 |
| PBT Margin (%) | 20.88 | 11.40 | 8.97 | 13.43 | 22.58 |
| Net Profit Margin (%) | 15.36 | 7.94 | 5.43 | 8.87 | 16.62 |
| NP After MI And SOA Margin (%) | 16.72 | 8.83 | 6.20 | 10.00 | 16.80 |
| Return on Networth / Equity (%) | 15.44 | 8.74 | 6.47 | 9.51 | 15.18 |
| Return on Capital Employeed (%) | 14.74 | 9.12 | 8.46 | 8.64 | 12.28 |
| Return On Assets (%) | 8.20 | 4.20 | 2.85 | 3.97 | 7.02 |
| Long Term Debt / Equity (X) | 0.24 | 0.42 | 0.62 | 0.66 | 0.63 |
| Total Debt / Equity (X) | 0.52 | 0.66 | 0.81 | 0.95 | 0.85 |
| Asset Turnover Ratio (%) | 0.49 | 0.47 | 0.45 | 0.43 | 0.52 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.37 | 1.56 | 2.03 | 1.53 | 2.01 |
| Quick Ratio (X) | 0.89 | 0.99 | 1.31 | 0.96 | 1.23 |
| Inventory Turnover Ratio (X) | 4.65 | 4.26 | 0.67 | 0.66 | 0.52 |
| Dividend Payout Ratio (NP) (%) | 10.70 | 18.56 | 36.02 | 31.94 | 21.54 |
| Dividend Payout Ratio (CP) (%) | 7.99 | 11.52 | 18.86 | 17.97 | 15.17 |
| Earning Retention Ratio (%) | 89.30 | 81.44 | 63.98 | 68.06 | 78.46 |
| Cash Earning Retention Ratio (%) | 92.01 | 88.48 | 81.14 | 82.03 | 84.83 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 8.81 | 5.12 | 3.25 | 7.06 | 18.14 |
| Interest Coverage Ratio (Post Tax) (%) | 5.41 | 2.95 | 1.84 | 3.53 | 10.61 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 1263.41 | 1279.65 | 1416.65 | 1555.60 | 2514.68 |
| EV / Net Operating Revenue (X) | 3.80 | 4.11 | 4.65 | 5.85 | 10.70 |
| EV / EBITDA (X) | 13.11 | 19.69 | 22.03 | 23.66 | 34.11 |
| MarketCap / Net Operating Revenue (X) | 3.23 | 3.43 | 3.88 | 4.86 | 9.83 |
| Retention Ratios (%) | 89.29 | 81.43 | 63.97 | 68.05 | 78.45 |
| Price / BV (X) | 2.98 | 3.39 | 4.05 | 4.62 | 8.88 |
| Price / Net Operating Revenue (X) | 3.23 | 3.43 | 3.88 | 4.86 | 9.83 |
| EarningsYield | 0.05 | 0.02 | 0.01 | 0.02 | 0.01 |
